Upadacitinib versus abrocitinib in real-world atopic dermatitis: a propensity score-weighted comparative effectiveness and safety analysis

The Journal of Allergy and Clinical Immunology: In Practice · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles